AoU Research Priorities Use Cases

Will the clinical use of predictive glycation and oxidation biomarkers improve diabetes care and prevent long-term complications

Since diabetic complications occur in those that show more glycative and oxidative stress, we have validated their predictive power in ground-breaking outcome trials to create diagnostic blood tests for clinical use.

To study the clinical efficacy and utility of these tests we will identify those at high risk (HR) before DKD and CVD are apparent. Primary endpoints are achievement of rigorous glycemic and proposed treatment goals in HR. Long-term goals are improved prevention of complications.

Keywords

Voting

11 votes
Ideate
Idea No. 653